OC
IHE icon

Oppenheimer & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Oppenheimer & Co’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$588K Hold
6,786
– – 0.01% 1118
2025
Q4 		$576K Hold
6,786
– – 0.01% 1020
2025
Q3 		$492K Hold
6,786
– – 0.01% 1176
2025
Q2 		$445K Hold
6,786
– – 0.01% 1180
2025
Q1 		$479K Hold
6,786
– – 0.01% 1090
2024
Q4 		$446K Hold
6,786
– – 0.01% 1111
2024
Q3 		$479K Hold
6,786
– – 0.01% 1046
2024
Q2 		$450K Hold
6,786
– – 0.01% 1032
2024
Q1 		$461K Hold
6,786
– – 0.01% 1021
2023
Q4 		$419K Buy
6,786
+195
+3% +$11.5K 0.01% 1023
2023
Q3 		$389K Hold
6,591
– – 0.01% 1035
2023
Q2 		$394K Hold
6,591
– – 0.01% 1058
2023
Q1 		$385K Hold
6,591
– – 0.01% 1039
2022
Q4 		$409K Buy
6,591
+138
+2% +$8.3K 0.01% 976
2022
Q3 		$365K Hold
6,453
– – 0.01% 1004
2022
Q2 		$412K Hold
6,453
– – 0.01% 989
2022
Q1 		$418K Hold
6,453
– – 0.01% 1072
2021
Q4 		$429K Hold
6,453
– – 0.01% 1099
2021
Q3 		$394K Hold
6,453
– – 0.01% 1114
2021
Q2 		$400K Hold
6,453
– – 0.01% 1115
2021
Q1 		$382K Hold
6,453
– – 0.01% 1078
2020
Q4 		$386K Hold
6,453
– – 0.01% 988
2020
Q3 		$352K Hold
6,453
– – 0.01% 924
2020
Q2 		$331K Hold
6,453
– – 0.01% 931
2020
Q1 		$289K Hold
6,453
– – 0.01% 911
2019
Q4 		$344K Hold
6,453
– – 0.01% 976
2019
Q3 		$301K Hold
6,453
– – 0.01% 983
2019
Q2 		$324K Hold
6,453
– – 0.01% 977
2019
Q1 		$331K Sell
6,453
-270
-4% -$13.4K 0.01% 994
2018
Q4 		$315K Buy
6,723
+270
+4% +$13.8K 0.01% 905
2018
Q3 		$361K Hold
6,453
– – 0.01% 997
2018
Q2 		$326K Sell
6,453
-69
-1% -$3.42K 0.01% 1026
2018
Q1 		$321K Hold
6,522
– – 0.01% 1021
2017
Q4 		$336K Buy
6,522
+69
+1% +$3.54K 0.01% 1015
2017
Q3 		$336K Hold
6,453
– – 0.01% 996
2017
Q2 		$334K Buy
6,453
+489
+8% +$24.7K 0.01% 988
2017
Q1 		$300K Sell
5,964
-57
-0.9% -$2.82K 0.01% 1000
2016
Q4 		$284K Sell
6,021
-741
-11% -$35.2K 0.01% 1016
2016
Q3 		$337K Buy
6,762
+15
+0.2% +$761 0.01% 945
2016
Q2 		$325K Sell
6,747
-6
-0.1% -$285 0.01% 940
2016
Q1 		$308K Sell
6,753
-48,453
-88% -$2.27M 0.01% 928
2015
Q4 		$2.98M Sell
55,206
-1,143
-2% -$60.1K 0.09% 260
2015
Q3 		$2.78M Buy
56,349
+5,124
+10% +$294K 0.08% 278
2015
Q2 		$2.98M Sell
51,225
-4,971
-9% -$290K 0.08% 285
2015
Q1 		$3.23M Buy
56,196
+3,357
+6% +$184K 0.09% 263
2014
Q4 		$2.67M Sell
52,839
-1,173
-2% -$57.2K 0.08% 310
2014
Q3 		$2.53M Buy
54,012
+2,664
+5% +$120K 0.08% 307
2014
Q2 		$2.31M Buy
51,348
+37,341
+267% +$1.61M 0.07% 336
2014
Q1 		$592K Buy
14,007
+8,043
+135% +$337K 0.02% 769
2013
Q4 		$235K Hold
5,964
– – 0.01% 1132
2013
Q3 		$212K Buy
+5,964
New +$210K 0.01% 1133

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Oppenheimer & Co's IHE Position: Q1 2026 in Review

Oppenheimer & Co held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 6,786 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #1118.

Oppenheimer & Co first reported a position in IHE in Q3 2013 and has held it in 51 quarters since. The position peaked at $3.23M in Q1 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Oppenheimer & Co held 6,786 shares of iShares US Pharmaceuticals ETF worth $588K as of Q1 2026.
  • Oppenheimer & Co left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
  • iShares US Pharmaceuticals ETF made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1118 holding.
  • Oppenheimer & Co first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and has held it in 51 quarters since.
  • Oppenheimer & Co's iShares US Pharmaceuticals ETF position peaked at $3.23M in Q1 2015.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.